🇺🇸 FDA
Pipeline program

ORMD-0801 (Insulin) capsule 8 mg BD

ORA-D-N02

Phase 2 small_molecule completed

Quick answer

ORMD-0801 (Insulin) capsule 8 mg BD for Diabetes Mellitus, Type 2 is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ORAMED PHARMACEUTICALS INC.
Indication
Diabetes Mellitus, Type 2
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials